AzTrials
AzTrials

Postoperative FistulaPhase 2EDIDPDNCT01634971

External Drainage Versus Internal Drainage of Pancreatic Duct With a Stent After Pancreaticoduodenectomy (EDIDPD)

A Phase 2 study testing Internal Drainage of Pancreatic Duct after pancreatomy in people with Postoperative Fistula and Complications of Surgical and Medical Care: General Terms, run by Tianjin Medical University Cancer Institute and Hospital at 1 site in China.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Postoperative pancreatic fistula (POPF) and other surgical complications are common after pancreatoduodenectomy (PD) and POPF is a major complication. The drainage of pancreatic duct is important and a stent is usually placed in the operation, but it is still controversial whether the stent drainage is internal or… Read more about this study

Who is it for?
Ages 18 to 80 years
What is being tested?
Internal Drainage of Pancreatic Duct after pancreatomy
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
120 participants
Where
1 siteChina
Study dates
May 2012to Dec 2016
Phase
Phase 2
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Age more than 18 years.
  • Received pancreatoduodenectomy.
  • Informed consent has been signed.

Who cannot join

  • Age less than 18 years
  • Emergency surgery
  • Past history of pancreatic surgery.

Trial locations and contacts

1 site in 1 country.

Qiang WU, MD. Ph.D. contact

18622221080

wuqiangtianjin@hotmail.com

China1 site, 1 recruiting
  • Tianjin Medical University Cancer Institute and Hospital

    Tianjin, Tianjin Municipality, 300060

    Qiang WU, MD. Ph.D., 18622221080, wuqiangtianjin@hotmail.com

    Qiang WU, MD. Ph.D.

    Recruiting

Other trials in China

About this study

Official title: Phase II Study of External Drainage Versus Internal Drainage of Pancreatic Duct With a Stent

Postoperative pancreatic fistula (POPF) and other surgical complications are common after pancreatoduodenectomy (PD) and POPF is a major complication. The drainage of pancreatic duct is important and a stent is usually placed in the operation, but it is still controversial whether the stent drainage is internal or external.

Read the detailed description

The current study is to compare the rate of Postoperative pancreatic fistula(POPF) and other surgical complications after pancreatoduodenectomy (PD).

Being tested
Internal Drainage of Pancreatic Duct after pancreatomy
Keywords
Postoperative pancreatic fistula(POPF);, Postpancreatectomy hemorrhage(PPH);, Delayed gastric emptying (DGE);, Bile leakage after pancreatic surgery;, Anastomotic leakage
Medical subject headings
Gastroparesis, Anastomotic Leak

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Internal Drainage of Pancreatic Duct after pancreatomyProcedure or surgery

    the Intervention name is: Internal Drainage of Pancreatic Duct after pancreatomy, a stent was placed in the pancreatic duct, external drainage of the stent is defined as control group(the stent will be tans-abdomen and as a drainage of pancreatic fluid), and internal drainage of the stent is defined as interventional(or experimental) group, with the stent very short(2cm) and placed in jejunum.

Study groups in NCT01634971
Study groupRoleWhat they receive
External Drainage of pancreatic ductNo interventionExternal Drainage of pancreatic duct was used in PD.
Internal Drainage of Pancreatic DuctExperimentalthe Intervention name is: Internal Drainage of Pancreatic Duct after pancreatomy, a stent was placed in the pancreatic duct, external drainage of the stent is defined as control group(the stent will be tans-abdomen and as a drainage of pancreatic fluid), and internal drainage of the stent is defined as interventional(or experimental) group, with the stent very short(2cm) and placed in jejunum.
Receives: Procedure: Internal Drainage of Pancreatic Duct after pancreatomy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. the rate of Postoperative pancreatic fistula within 2 weeks after operation

    Postoperative pancreatic fistula (POPF) is defined as a drain output of any measurable volume of fluid on or after postoperative day 3 with an amylase content greater than 3 times the serum amylase activity.

    Measured: within 2 weeks after operation

Secondary outcomes (1)
  1. the rate of postoperative Surgical Complications

    the rate of Postpancreatectomy hemorrhage(PPH);Delayed gastric emptying (DGE); Bile leakage after pancreatic surgery;Anastomotic leakage

    Measured: 2 weeks after operation

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Jul 2012 (estimated)
  2. Study startMay 2012
  3. Primary completionDec 2016 (estimated)
  4. Study completionDec 2016 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 2
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Triple blind
Who is masked
Participant, Care provider, Investigator
Enrolment
120 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01634971
Sponsor's protocol ID
CIH-WUQ-201205001
Other IDs
E2012010
Acronym
EDIDPD
Status last verified
Jan 2013
First submitted
3 Jul 2012
Last updated
17 Feb 2016
Results posted
No
Data monitoring committee
Yes

Questions about this trial

What is this clinical trial studying?

A Phase 2 study testing Internal Drainage of Pancreatic Duct after pancreatomy in people with Postoperative Fistula and Complications of Surgical and Medical Care: General Terms, run by Tianjin Medical University Cancer Institute and Hospital at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 17 Feb 2016. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Qiang WU, MD. Ph.D. (18622221080, wuqiangtianjin@hotmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

the rate of Postoperative pancreatic fistula within 2 weeks after operation (time frame: within 2 weeks after operation). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Feb 2016.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in